Close
Nordic 9Nordic 9

Opna Bio (private company)

Switzerland opnabio.com
See something wrong or missing? Let us know
Offices:Lausanne
Industry:BiotechHealth servicesManufacturing
Business model:B2B

Opna Bio is a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 38M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Opna Bio

Name Criteria
Germany CatalYm
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
France InnovaFeed SAS
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Peptone
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Austria Sarcura
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Switzerland Synendos Therapeutics
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
France Eyevensys
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Mestag Therapeutics
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Germany Emergence Therapeutics
65%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 3
  • Total raised in a similar range: 10M+ USD
Top